Fluorescent-labeled anti-inflammatory α-galactosylceramide derivative and its intracellular behavior associated with

Shunya Kikuchi1, Takanori Matsumaru2, Yukari Fujimoto1

  • 1Department of Chemistry, Faculty of Science and Technology, Keio University. Yokohama, 223-8522, Japan; Human Biology Microbiome Quantum Research Center (Bio2Q), Keio University. Tokyo, 160-8582, Japan.

Insights

Researchers developed a novel glycolipid antigen labeling method to track immune cell interactions. This technique visualizes how specific antigens are taken up by CD1d-expressing cells, aiding in understanding immune modulation.

Area of Science:

  • Immunology
  • Cell Biology

Background:

  • Immune activity is modulated by glycolipid antigens via CD1d-dependent recognition.
  • This interaction involves CD1d-glycolipid complexes and Natural Killer T (NKT) cell cytokine induction.

Purpose of the Study:

  • To develop a novel and effective glycolipid antigen labeling method.
  • To investigate the cellular uptake and presentation of anti-inflammatory α-GalCer-Bz amide using fluorescent probes.

Main Methods:

  • Developed a novel GalCer labeling method for α-GalCer-Bz amide.
  • Utilized confocal microscopy to observe the uptake of labeled KRN7000-type and α-GalCer-Bz amide-type compounds into CD1d-expressing cells.
  • Tracked cell surface antigen presentation by visualizing CD1d-glycolipid antigen complexes.

Main Results:

  • Observed cellular uptake of fluorescently labeled glycolipid antigens into CD1d-expressing cells.
  • Demonstrated that the cellular uptake of α-GalCer-Bz amide is CD1d-dependent.
  • Showed rapid cell surface presentation of α-GalCer-Bz amide as a CD1d-complex.

Conclusions:

  • The novel labeling method allows visualization of glycolipid antigen-CD1d interactions.
  • The cellular behavior of glycolipid antigens, particularly α-GalCer-Bz amide, is CD1d-dependent.
  • Findings provide a basis for understanding immune modulation by glycolipid antigens.